Posted by Michael Wonder on 08 Aug 2019
AstraZeneca CEO on drug prices: the system has to change
8 August 2019 - As part of the Trump administration’s broader efforts to reform health care, President Trump has lead a push to lower drug prices for U.S. consumers, but it is uncertain how the potential reforms will impact pharmaceutical companies.
AstraZeneca CEO Pascal Soriot weighed in telling the FOX Business ‘Varney & Co.’, “We may be [affected], I mean, actually nobody knows what the outcome of the discussions will be.”
